Posted inBiotechnology
Exploring Belgium’s Livestock Transition: Narratives and Trade-offs
In a pioneering study published in npj Sustainable Agriculture, researchers have delved into the complex pathways of transitioning Belgium’s livestock…
Posted inBiotechnology
Studying Postoperative Frailty in Elderly Patients: Insights
In the realm of healthcare, the intricacies of postoperative recovery, particularly in older adults, are gaining unprecedented attention. Recent research…
Posted inBiotechnology
Evommune’s Dupixent-like phase 2 eczema data drive 75% stock rally
Evommune has aced its first major test as a public company, reporting phase 2a eczema data that caused its share price…
Posted inBiotechnology
AstraZeneca reveals oral GLP-1 scored phase 2 wins but holds back weight loss data
AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss…
Posted inMedical Technology
Merck teams up with British medtech to boost vaginal therapeutics delivery system
German Merck has set up a new collaboration with U.K. medtech company Calla Lily Clinical Care to work on its…
Posted inBiotechnology
New Co-Editor-in-Chief Ushers Fresh Vision
Inaugural Message from the New Co-Editor-in-Chief of Light: Science & Applications The prestigious scientific community welcomes a momentous announcement from…
Posted inBiotechnology
Study Finds Obesity Increases Risk of Serious Infections by 70%, Linking One in Ten Global Infectious Disease Deaths to Obesity
A groundbreaking study published in The Lancet has revealed that obesity significantly amplifies the risk of severe infections necessitating hospitalization…
Posted inBiotechnology
Parents of Medically Complex Children Face Significant Challenges with At-Home Medical Devices
In recent years, the reliance on medical devices to manage children with complex health needs at home has grown substantially.…
Posted inBiotechnology
Symptoms Impacting Health Quality in Swedish Older Men
In a groundbreaking study published in BMC Geriatrics, researchers have embarked on an exploration into the prevalence of symptoms experienced…
Posted inBiotechnology
AstraZeneca relaxed about relaxin drug’s poor efficacy in phase 2 heart failure trial
AstraZeneca executives have told Fierce Biotech they still see potential in harnessing the relaxin hormone to treat heart failure despite…